From Lab to Launch by Qualio

EXPLORE

Society & Culture

Health & Fitness

© 2024 PodJoint

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/e1/7d/79/e17d7907-11f5-5b67-9c09-1742f6c362b2/mza_13936292744885722769.jpg/600x600bb.jpg

From Lab to Launch by Qualio

Qualio

122 episodes

1 week ago

Today we’re talking to Mohan Uttarwar, an accomplished entrepreneur and innovator with extensive expertise in life sciences and precision diagnostics, as he walks us through his fascinating journey from an Indian village without electricity to the bleeding edge of Silicon Valley tech innovation. Mohan's work focuses on addressing unmet needs in oncology and personalized medicine, and he’s particularly focused on the development of next-generation diagnostic tools, specifically in the areas of...

Show more...

Entrepreneurship,

All content for From Lab to Launch by Qualio is the property of Qualio and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Today we’re talking to Mohan Uttarwar, an accomplished entrepreneur and innovator with extensive expertise in life sciences and precision diagnostics, as he walks us through his fascinating journey from an Indian village without electricity to the bleeding edge of Silicon Valley tech innovation. Mohan's work focuses on addressing unmet needs in oncology and personalized medicine, and he’s particularly focused on the development of next-generation diagnostic tools, specifically in the areas of...

Show more...

Entrepreneurship,

Episodes (20/122)

From Lab to Launch by Qualio

Rural India to Silicon Valley: an entrepreneur's journey with Mohan Uttarwar, co-founder & CEO of 1Cell.AI

Today we’re talking to Mohan Uttarwar, an accomplished entrepreneur and innovator with extensive expertise in life sciences and precision diagnostics, as he walks us through his fascinating journey from an Indian village without electricity to the bleeding edge of Silicon Valley tech innovation. Mohan's work focuses on addressing unmet needs in oncology and personalized medicine, and he’s particularly focused on the development of next-generation diagnostic tools, specifically in the areas of...

1 week ago

29 minutes

From Lab to Launch by Qualio

The magic formula of population-based predictive analytics with Dr. Terrance Govender, VP of Medical Affairs at ClinIntell

Today on From Lab To Launch, we’re excited to welcome Dr. Terrance Govender, the VP of Medical Affairs at ClinIntell. ClinIntell, based in Tampa, Florida, supports healthcare executives and leaders in accurately capturing the true severity of their inpatient population using population-based predictive analytics. The results for their customers? More accurate, trustworthy performance data and clinical condition reporting, that can be easily shared and used to drive continuous improvemen...

3 weeks ago

18 minutes

From Lab to Launch by Qualio

The proof is in the protein with Dr. Jonathan Usuka, CEO of Sapient

If you’ve been following From Lab to Launch for a while, you may remember a previous conversation with Sapient’s Chief Scientific Officer, Dr. Mo Jain, a couple years back. We’re thrilled to build on that conversation with Dr. Jonathan Usuka, the CEO of Sapient. Sapient is one of the largest capacity biomarker discovery labs in the world, and their mission is to accelerate drug development and improve patient outcomes through biomarker-guided therapeutics. By combining high-resolution b...

1 month ago

16 minutes

From Lab to Launch by Qualio

Building the world of life science AI with Ilya Burkov, Global Head of Healthcare & Lifesciences Growth at Nebius AI

In this episode, Meg speaks to Ilya Burkov, the Global Head of Healthcare & Lifesciences Growth at Nebius AI. Nebius AI’s goal is simple: to provide the cloud infrastructure that will be the groundwork of the AI revolution we can all see happening in front of us. Nebius’ suite of tools helps life science companies gather data and then train, fine-tune and launch their AI models into the world. Ilya’s role is to oversee and drive the adoption of this cloud AI technology within the life sci...

1 month ago

26 minutes

From Lab to Launch by Qualio

3D printing medical devices with John Kawola, CEO of Boston Micro Fabrication

When we think of medical devices and how they’re built, 3D printing isn’t necessarily the first thing that comes to mind. But Boston Micro Fabrication is at the cutting edge of an exciting development in how life-saving devices are prototyped and created. With the news that the FDA is pivoting away from animal testing towards 3D organoids, and with the growing need to produce miniature, intricate and high-quality devices at speed, BMF’s nanometer-precise microArch 3D printing technology...

2 months ago

20 minutes

From Lab to Launch by Qualio

Stopping the bleeding with Dr. Francesco Viola, Founder and Chief Scientific Officer, HemoSonics

If you’ve ever seen a medical drama, you know how intense it gets when a patient is bleeding and doctors have to act fast. But in real life, understanding why someone is bleeding—and how best to stop it—isn’t always straightforward. That’s where Dr. Francesco Viola’s work at HemoSonics comes in. HemoSonics provides a solution for doctors to get a clear picture of how a patient’s blood is clotting. Instead of waiting for slow lab results or guessing which blood products to give, doctors can no...

3 months ago

18 minutes

From Lab to Launch by Qualio

Developing the undevelopable with Dave Miller, Chief Science Officer at AustinPx

As complexity in pharmaceutical development reaches new heights — especially with over 60% of recent FDA novel molecular entities falling outside traditional drug design rules — the need for advanced formulation and manufacturing strategies has never been greater. Precision medicine is no longer a future goal; it’s a present necessity. And that’s exactly where AustinPx comes in. At the forefront of this shift is AustinPx’s KinetiSol technology, a powerful platform designed to make the “undeve...

4 months ago

44 minutes

From Lab to Launch by Qualio

Unlocking cell secrets with Julien Bradley, CEO of Axion BioSystems

Understanding how cells interact is a critical cornerstone of modern life science, and Axion BioSystems is right at the confluence of live-cell analysis and next-generation technology. Axion’s Maestro and Multiwell products are helping to unlock the secrets of cellular behavior and allow the tracking of the health and function of thousands of cells at once, in real time. CEO Julien Bradley joined Meg on the show to discuss why understanding cellular behavior is so important - and ...

5 months ago

22 minutes

From Lab to Launch by Qualio

Hunting the perfect molecule with Dr. James Field, CEO of LabGenius Therapeutics

Today we’re heading across the Atlantic to speak to Dr. James Field, CEO of London-based LabGenius Therapeutics. LabGenius has a really exciting mission. James and his team of 60 scientists and engineers believe in the powerful combination of human and artificial intelligence, and are pioneering an ML-driven protein engineering platform - EVA - that can design and execute experiments for the development of next-gen antibodies, including complex multispecifics. LabGenius has already raised ove...

6 months ago

23 minutes

From Lab to Launch by Qualio

Special episode! Digging into Qualio's 2025 quality trends report

We made a bonus episode of From Lab To Launch to mark a special occasion: the launch of Qualio's fourth annual life science quality trends report in March 2025. Our very own Kat and Clive dug into the report and its fascinating findings to see how life science quality teams are spending their time, what they're planning for 2025, and what headaches and frustrations they're looking to conquer this year. Join us and dive into our report - and read the full thing at reports.qualio.com! Note:...

7 months ago

15 minutes

From Lab to Launch by Qualio

Mind the gap! Advancing transplantation with Tina Liedtky, President of the Transplant Diagnostics Division, Thermo Fisher Scientific

As the organ transplant list continues to grow, experts in the transplant diagnostics industry are looking for ways to address the supply and demand challenges within the field. New tactics, like retransplantation and xenotransplantation, and new testing methods, such as HLA testing and transplant diagnostics, are being explored to boost transplant success rates and ensure more patients get the lifesaving transplants they need. As President of Thermo Fisher Scientific’s transplant...

7 months ago

20 minutes

From Lab to Launch by Qualio

The predictive power of biomarkers with Mark Roskey, CSO of Quanterix

As more preventative approaches to health are set to take center stage, some diseases can’t be prevented but can be managed more proactively. Blood-based biomarkers, such as p-tau217, hold great promise for earlier, more proactive detection and monitoring of diseases such as Alzheimer’s, and it’s here that Quanterix plays a critical role. Their Simoa digital health platform serves as the backbone for the majority of p-tau217 tests on the market today, reducing reliance on costly PET and CSF t...

8 months ago

16 minutes

From Lab to Launch by Qualio

Advancing Pathology using AI with Joseph Mossel Co-founder & CEO of Ibex

In this episode of From Lab to Launch by Qualio we interview Joseph Mossel, CEO and co-founder of Ibex Medical Analytics. Joseph shares his journey from computer science to leading a transformative AI-driven company in pathology. Founded in 2016, Ibex aims to provide accurate, timely, and personalized cancer diagnoses using AI technology. Joseph discusses the challenges and insights from deploying AI in clinical settings, the importance of partnerships, and the company's vision for the next f...

11 months ago

28 minutes

From Lab to Launch by Qualio

The future of clinical trials with Sarah Englert, Senior Director of Innovation & Program Management at Thermo Fisher Scientific

Earlier this year, Thermo Fisher Scientific opened its first clinical trial Innovation Lab in Center Valley, Pa., designed to foster a culture of collaboration by providing a dedicated space for industry partners to come together, share ideas and co-create solutions for the industry’s biggest challenges. The global clinical trial market was valued at over $80 billion in 2023, and that’s projected to grow by 6.5% every year until 2030. But alleviating innovation silos is the only way to m...

1 year ago

25 minutes

From Lab to Launch by Qualio

The future of protein manufacturing with Kerry Love, co-founder of Sunflower Therapeutics

Today we welcome Kerry Love, the co-founder of Massachusetts-based (and wonderfully named) Sunflower Therapeutics. Established in 2018, Sunflower is dedicated to advancing biologic medicines and enhancing global vaccine accessibility through cutting-edge protein manufacturing technologies.As a women-owned organization, Sunflower has a stellar team of scientists and engineers renowned for their expertise in perfusion fermentation, purification process development, biopharmaceutical manufacturi...

1 year ago

19 minutes

From Lab to Launch by Qualio

Revolutionizing kidney health with Salvatore Viscomi, CEO of Carna Health

Carna Health is focused on applying technology to revolutionize kidney care by unlocking the early detection and management of chronic kidney disease (CKD). They provide clinical-grade software as medical devices that deliver instant health metrics, such as creatinine, eGFR, and uACR levels, from small patient samples. Their platform integrates with existing healthcare systems and electronic healthcare records, promoting proactive and patient-centric care underpinned by accurate, real-time pa...

1 year ago

25 minutes

From Lab to Launch by Qualio

Pioneering in Genetic Research with Dr. Jonathan Hill of Wasatch Biolabs

Dr. Jonathan Hill, VP of Science and Technology and co-founder of Wasatch Biolabs joins the podcast today to talk about the future of genetic testing technology. Dr. Hill shares his journey in genetics, starting from his undergraduate days to co-founding multiple biotech companies. They discuss the cutting-edge genomic and bioinformatic methods being developed at Wasatch Biolabs, including targeted DNA methylation sequencing and its significant implications for personalized medicine and early...

1 year ago

29 minutes

From Lab to Launch by Qualio

Sepsis Detection Made Rapid and Accurate with Dr. Rolland Carlson CEO of Immunexpress

Join us with guest Dr. Rolland Carlson, CEO of Immunexpress to talk about the transformative work happening in sepsis diagnosis. Dr. Carlson discusses the importance of rapid sepsis diagnosis. The episode covers challenges faced during product development, regulatory achievements, and future plans for sepsis diagnostics. Dr. Carlson also shares advice on ensuring product quality and navigating FDA clearances.00:00 Introduction to From Lab to Launch00:25 Meet Dr. Rolland Carlson, CEO of Immune...

1 year ago

28 minutes

From Lab to Launch by Qualio

Continuing Early Cancer Detection with David Suhy Co-founder of Earli

In this episode we bring David Suhy, co-founder and Chief Scientific Officer at Earli back to the podcast. David shares the heartfelt founding story of Earli, the company's mission to make cancer a benign experience by catching it early, and their unique approach utilizing synthetic promoters for early cancer detection and treatment. He discusses challenges faced in clinical trials, the importance of quality and safety in research, and provides advice for other startups in life sciences. Davi...

1 year ago

29 minutes

From Lab to Launch by Qualio

Innovative Approaches to Medication-Assisted Addiction Treatment with Dr. Joshua Lee

This episode we're joined by Dr. Joshua Lee, a clinician, researcher, and professor specializing in medication-assisted treatment (MAT) for alcohol and opioid use disorders. Dr. Lee discusses his extensive research on medications such as naltrexone and buprenorphine, their significance in treating substance use disorders, and the transformative potential of telemedicine platforms like Oar Health. He highlights the underutilization of effective medications in primary care, the barriers to acce...

1 year ago

32 minutes